3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
33
Phase 1/2
19
Phase 1
19
Phase 4
2
Phase EARLY_PHASE1
1
Phase 3
1
Status
Completed
3
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Skin Neoplasms
2
Melanoma
2
Neoplasm Metastasis
1
Interventions
Saline Solution
6
Fentanyl
6
Sodium Chloride
5
Letrozole
5
Dexamethasone
5
Pregabalin
4
Ketamine
4
Goserelin
4
Gemcitabine
4
Bevacizumab
4
Tranexamic Acid
3
Photochemotherapy
3
Pemetrexed
3
Paclitaxel
3
Metformin
3
Leuprolide
3
Docetaxel
3
Cyclophosphamide
3
Carboplatin
3
Capecitabine
3
Acetaminophen
3
ulipristal acetate
2
sodium glycididazole
2
nilotinib
2
liposomal doxorubicin
2
human papillomavirus vaccine, L1 type 16, 18
2
flurbiprofen axetil
2
fludarabine
2
fluciclovine F-18
2
epoetin beta
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Terminated
×
aldesleukin
×
Clear all
NCT01856023
2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4
Terminated
29 enrolled
9 charts
NCT01683188
2021-02-01
PROCLIVITY01
Clinigen, Inc.
Phase 4
Terminated
53 enrolled